Is peritoneal dialysis still an equal option?
Based on our results, NHD results in significantly improved parameters of uremia and nutrition. If individually and logistically possible, NHD should be the treatment modality of preference for older children and adolescents.
Mh7 is a new hepatocellular membrane monoclonal antibody and may closely related with liver diseases.